Focus:
News
-
17 February 2020
Merck’s Ebola vaccine Ervebo available in four African countries
Merck (MSD) has received approval from four African countries for its Ervebo vaccine to prevent disease caused by Zaire ebolavirus.
-
17 February 2020
Coronavirus Covid-19: China uses traditional medicine for treatment
China is reportedly using traditional medicine to treat patients with Covid-19 caused by the novel coronavirus, which emerged in the country in December last year.
-
17 February 2020
Coronavirus: A timeline of how the deadly Covid-19 outbreak is evolving
Here's the timeline of how the Coronavirus outbreak evolved from Wuhan city in China and is spreading across the world.
-
17 February 2020
Coronavirus Covid-19 death toll at 1,775; Taiwan reports first death
The coronavirus Covid-19 death toll has reached 1,775 with 105 new deaths in China and one in Taiwan, as of the end of 16 February. In mainland China, the toll...
-
17 February 2020
Zydus Cadila looks to expedite Covid-19 vaccine development
India-based pharmaceutical firm Zydus Cadila has launched a fast-tracked research programme to develop a vaccine against the disease caused by the new coronavirus, Covid-19.
-
16 February 2020
Coronavirus Covid-19: Death toll rises to 1,669; France reports first death
The coronavirus Covid-19 has claimed 1,669 lives with 142 new deaths in China and one in France as of the end of 15 February. The total number of deaths in...
-
15 February 2020
Covid-19 death toll increases to 1,526; Egypt records first infected case
The death toll due to the new coronavirus Covid-19 has increased to 1,526 with 143 new deaths in China as of the end of 14 February. The total number of...
-
14 February 2020
FDA withdraws Eisai’s weight management drug Belviq due to cancer risk
The US Food and Drug Administration (FDA) has requested that Eisai voluntarily withdraw its weight management drug Belviq (lorcaserin) from the US market. Eisai has “submitted a request to voluntarily...
-
14 February 2020
Codagenix partners Serum Institute of India on Covid-19 vaccine
Biotechnology firm Codagenix has partnered with vaccine manufacturer Serum Institute of India to work together for the development of a vaccine for the new coronavirus.
-
14 February 2020
Preclinical data of Gilead’s remdesivir raises hope for China trials
A study by the US National Institutes of Health (NIH) has demonstrated that Gilead’s antiviral drug, remdesivir, could prevent a type of coronavirus in monkeys.